Safety of Autologous Umbilical Cord Blood Therapy for Acquired Sensorineural Hearing Loss in Children
Description: This article presents the results of a phase 1 clinical trial to evaluate the intravenous administration of human umbilical cord blood (hUCB) mononuclear fraction in infants and children with acquired sensorineural hearing loss (SNHL).
Date: June 18, 2018
Creator: Baumgartner, Linda S.; Moore, Ernest J.; Shook, David; Messina, Steven; Day, Mary Clare; Green, Jennifer et al.
Partner: UNT College of Public Affairs and Community Service